IL10 and glioblastoma: In the recent scRNA seq study, it was established that T cells, spatially co-localized with HMOX1+ (immunosuppressive phenotype) myeloid cells in mesenchymal-like areas of GBM [124], express markers of dysfunction, and their suppression is associated with IL10 present in the TME.